Excuse me Ann -- you're way ahead of me. I'll copy and paste.
Plse note readers: this is a committee making policy decisions on vaccine rollout.
Agenda Item III
The following members declared interests in companies that manufacture and supply influenza vaccines (Abbott, AstraZeneca, Baxter, Crucell, GSK, MASTA, Novartis, Pfizer, Sanofi-Pasteur MSD)
Ray Borrow
Non-personal, non-specific GSK, Baxter, Novartis, Pfizer and Sanofi-Pasteur MSD
The member is able to participate in the discussion and to vote
Judith Breuer
Non-personal, non-specific Sanofi-Pasteur MSD
The member is able to participate in the discussion and vote
Anthony Harden
Personal, non-specific AstraZeneca
The member is able to participate in the discussion but not to vote
Pauline MacDonald
Personal, non-specific GSK
The member is able to participate in the discussion but not to vote
Anne McGowan
Non-personal, non-specific GSK and Sanofi-Pasteur MSD
The member is able to participate in the discussion and to vote
Andrew Riordan
Non-personal, non-specific GSK
The member is able to participate in the discussion and to vote
Professor John Edmunds (LSHTM), an author of the cost effectiveness study, also declared a personal, non-specific interest in GSK. He presented the study and discussed the findings.